LIVE MARKET TRACKER :   BSE SENSEX   26429.85      |    NSE NIFTY 7879.40    
GLOBAL MARKETS :  NASDAQ 4258.438   +0.97%    |    FSI London 6247.55   -0.99%    |    NIKKEI Japan 15111.23   +3.98%
  USD GBP EUR CAD AUD INR
USD - 0.6201 0.7824 1.1263 1.1417 61.318
GBP 1.6127 - 1.2618 1.8164 1.8412 98.8857
EUR 1.2783 0.7927 - 1.4398 1.4595 78.3859
CAD 0.8883 0.5508 0.695 - 1.0141 54.4662
AUD 0.8761 0.5433 0.6854 0.9867 - 53.7189
INR 0.0163 0.0101 0.0128 0.0184 0.0186 -
Indian-Commodity  :  Equity & Shares  :  Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug

Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug (10-Dec-2012)

Dr Reddy's Lab is currently trading at Rs. 1845.00, up by 6.65 points or 0.36% from its previous closing of Rs. 1838.35 on the BSE.

The scrip opened at Rs. 1844.80 and has touched a high and low of Rs. 1846.95 and Rs. 1833.70 respectively. So far 1923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1850.00 on 06-Dec-2012 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1850.00 and Rs. 1804.00 respectively. The current market cap of the company is Rs. 31,321 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 39.75% and 17.76% respectively.

Dr Reddy's Laboratories, has introduced PamorelinO LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland. The company will import this drug in bulk from Debio Recherche Pharmaceutique and made available primarily to urologists and oncologists across India. PamorelinO LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs 


Top News Today
RBI governor hopes the economy to grow by 5.5% this year
(17-Oct-2014)

RBI governor hopes the economy to grow by 5.5% this yearReserve Bank of India (RBI) governor Raghuram Rajan has expressed hopes on the Indian growth story and has said that the country is seeing a pick-up in economic growth and more can be done to support it......click on news to read complete article.

Tata Steel, UltraTech and NTPC to see some action today
(16-Oct-2014)

Tata Steel, UltraTech and NTPC to see some action todayTata Steel has signed a memorandum of understanding with the Geneva-based Klesch group for the potential sale of its long products business in Europe and associated distribution activities. The division......click on news to read complete article.

September CPI eases to an all time low level of 6.46%
(14-Oct-2014)

September CPI eases to an all time low level of 6.46%In an extremely encouraging development, India's consumer price inflation eased at an all time low level since the launch of the new series of Consumer Price Index in 2012, at 6.46% in September as compared......click on news to read complete article.

International Stock News
US markets closed higher; Dow snaps 6-day losing streak
(18-Oct-2014)

US markets closed higher; Dow snaps 6-day losing streakThe US markets closed higher on Friday, with Dow snapping 6-day losing streak, as earnings beat estimates, consumer confidence reached a seven-year high and investors speculated that central banks will......click on news to read complete article.

US markets closed mostly higher; Dow ends in red
(17-Oct-2014)

US markets closed mostly higher; Dow ends in redThe US markets closed mostly higher on Thursday, recovering from early losses though Dow ended in red. The gains were induced with Bullard statement that the Federal Reserve should consider extending its......click on news to read complete article.

US markets closed lower on weak economic data
(16-Oct-2014)

US markets closed lower on weak economic dataThe US markets closed lower on Wednesday, on account of weak economic data, stocks however recovered from their lowest level of the day before the close. On the economy front, sales at US retailers fell......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.